Primary CNS Nonamyloidogenic Light Chain Deposition Disease: Case Report and Brief Review
Juan Jose Mercado1, James M Markert1, William Meador1
11 University of Alabama, Birmingham, AL, USA.
Light chain deposition disease (LCDD) is a rare condition affecting the central nervous system (CNS). This case highlights an unusual presentation of LCDD in the brain, emphasizing its rarity and diagnostic challenges.
Area of Science:
- Neurology
- Nephrology
- Pathology
Background:
- Light chain deposition disease (LCDD) is a rare systemic disorder characterized by the extracellular deposition of monoclonal immunoglobulin light chains.
- LCDD primarily affects the kidneys but can involve other organs, including the central nervous system (CNS).
- The true incidence of LCDD restricted to the CNS is largely unknown, with very few cases previously reported.
Observation:
- A 44-year-old man presented with progressive neurological deficits, including hypoesthesia and weakness.
- Brain biopsy revealed amorphous, Congo red-negative, amyloid-like deposits in the white matter and vessels.
- Deposits showed kappa light chain restriction by chromogenic in situ hybridization (CISH) and immunohistochemistry.
Findings:
- The patient was diagnosed with light chain deposition disease (LCDD) limited to the CNS.
- Systemic workups for myeloma and lymphoma were negative, suggesting a primary CNS manifestation.
- The observed deposits were amyloid-like but Congo red-negative, a characteristic feature of LCDD.
Implications:
- This case expands the understanding of rare CNS manifestations of light chain deposition disease (LCDD).
- Accurate diagnosis requires specialized techniques like CISH and immunohistochemistry to identify light chain restriction.
- Further research is needed to elucidate the pathogenesis and incidence of LCDD restricted to the CNS.
More Related Videos
10:03Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons
Published on: August 16, 2020
09:31Visualization of Amyloid β Deposits in the Human Brain with Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry
Published on: March 7, 2019
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid Fibrils
Lysosomal Hydrolases
Parkinson's Disease: Overview
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
